An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
This treatment has been approved for sale to the public.
First Posted: July 7, 2009
Last Update Posted: November 30, 2016
Information provided by: